Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
CAI | Caris Life Sciences, Inc. | Director | $18.3M | Aug 11, 2025 | ||
EXEL | EXELIXIS, INC. | Director | $6.47M | -$2.52M | -28% | May 29, 2025 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|